BRPI0912506A2 - composição emoliente - Google Patents

composição emoliente

Info

Publication number
BRPI0912506A2
BRPI0912506A2 BRPI0912506A BRPI0912506A BRPI0912506A2 BR PI0912506 A2 BRPI0912506 A2 BR PI0912506A2 BR PI0912506 A BRPI0912506 A BR PI0912506A BR PI0912506 A BRPI0912506 A BR PI0912506A BR PI0912506 A2 BRPI0912506 A2 BR PI0912506A2
Authority
BR
Brazil
Prior art keywords
composition
rtm
vaseline
water
petroleum jelly
Prior art date
Application number
BRPI0912506A
Other languages
English (en)
Inventor
Christophe Przybylski
Jean-François Cordoliani
Marion Kopec
Pierre Fabre
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of BRPI0912506A2 publication Critical patent/BRPI0912506A2/pt
Publication of BRPI0912506B1 publication Critical patent/BRPI0912506B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Developing Agents For Electrophotography (AREA)
BRPI0912506-0A 2008-05-16 2009-05-18 Composição emoliente de uso tópico e utilização da mesma BRPI0912506B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0853187 2008-05-16
FR0853187A FR2931073B1 (fr) 2008-05-16 2008-05-16 Composition emolliente
PCT/EP2009/056021 WO2009138517A1 (fr) 2008-05-16 2009-05-18 Composition emolliente

Publications (2)

Publication Number Publication Date
BRPI0912506A2 true BRPI0912506A2 (pt) 2015-10-13
BRPI0912506B1 BRPI0912506B1 (pt) 2019-04-16

Family

ID=40028914

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912506-0A BRPI0912506B1 (pt) 2008-05-16 2009-05-18 Composição emoliente de uso tópico e utilização da mesma

Country Status (27)

Country Link
US (1) US20110071226A1 (pt)
EP (2) EP2323639A1 (pt)
JP (1) JP5653911B2 (pt)
KR (1) KR20110023858A (pt)
CN (2) CN104189005A (pt)
AT (1) ATE523192T1 (pt)
AU (1) AU2009248047B2 (pt)
BR (1) BRPI0912506B1 (pt)
CA (1) CA2724522A1 (pt)
CY (1) CY1112150T1 (pt)
DK (1) DK2119435T3 (pt)
ES (1) ES2370465T3 (pt)
FR (1) FR2931073B1 (pt)
GE (1) GEP20135900B (pt)
HK (1) HK1203828A1 (pt)
HR (1) HRP20110905T1 (pt)
IL (1) IL209334A (pt)
MA (1) MA32396B1 (pt)
MX (1) MX2010012352A (pt)
NZ (1) NZ589971A (pt)
PL (1) PL2119435T3 (pt)
PT (1) PT2119435E (pt)
RU (1) RU2493834C2 (pt)
SI (1) SI2119435T1 (pt)
UA (1) UA101035C2 (pt)
WO (1) WO2009138517A1 (pt)
ZA (1) ZA201009033B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2241351A1 (en) * 2009-04-16 2010-10-20 Orfagen Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis
FR2957260B1 (fr) * 2010-03-15 2012-04-27 Fabre Pierre Dermo Cosmetique Nouvelle formulation dermocorticoide
CN102488624B (zh) * 2011-12-13 2013-12-04 中山市天图精细化工有限公司 用于个人护理的凡士林气雾剂组合物
EP2845591A1 (en) * 2013-09-04 2015-03-11 Polichem S.A. Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions
FR3013985B1 (fr) * 2013-12-03 2017-11-03 Galephar M/F Compositions hydratantes comprenant au moins un extrait de caesalpinia spinosa, avec au moins de la vaseline et de la glycerine
DE102013225372A1 (de) * 2013-12-10 2015-06-11 Henkel Ag & Co. Kgaa Wärmende Öl-Haarkur
FR3024360A1 (fr) * 2014-07-30 2016-02-05 Pf Medicament Emulsions aux stearates
FR3090385B1 (fr) 2018-12-21 2021-01-08 Pf Medicament Composition émolliente sous forme d’émulsion

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2023786B2 (de) * 1970-05-15 1973-03-01 Wasser-in-oel-emulgatoren
SU925990A1 (ru) * 1980-06-26 1982-05-07 Уфимский Нефтяной Институт Способ получени медицинского вазелина
IL69353A0 (en) * 1983-07-27 1984-01-31 Berman Daniel Skin ointment comprising herbal extracts
PL162396B3 (pl) * 1989-12-07 1993-10-30 Akademia Medyczna Im Mikolaja Krem chroniacy skóre przed wodnymi roztworami elektrolitów PL
US5512278A (en) * 1994-01-11 1996-04-30 Phylomed Corporation Ointment base useful for pharmaceutical preparations
ES2183430T3 (es) * 1997-12-03 2003-03-16 Johnson & Johnson Consumer Composicion para el cuidado de la piel con capacidad mejorada de hidratacion de la misma.
FR2826659B1 (fr) * 2001-07-02 2005-11-11 Aldivia Substitut de lanoline, son procede d'obtention et ses applications
FR2831443B1 (fr) 2001-10-30 2005-02-11 Oreal Utilisation d'extraits vegetaux pour ameliorer la fonction barriere de la peau
FR2847467B1 (fr) 2002-11-25 2006-05-26 Oreal UTILISATION D'UN AGENT MODULATEUR DE L'ACTIVITE DE L'OXYSTEROL 7alpha-HYDROXYLASE POUR LE TRAITEMENT COSMETIQUE DE DESORDRES CUTANES
CN1552303A (zh) * 2003-06-03 2004-12-08 张金铎 美白霜及其制备方法
CN1927157A (zh) * 2005-09-08 2007-03-14 天津市世雄科技发展有限公司 夏令驱虫防晒油膏
FR2905857B1 (fr) 2006-09-20 2011-02-11 Chanel Parfums Beaute Utilisation d'un extrait de pulpe de caroube pour hydrate la peau

Also Published As

Publication number Publication date
US20110071226A1 (en) 2011-03-24
EP2323639A1 (fr) 2011-05-25
GEP20135900B (en) 2013-08-12
AU2009248047B2 (en) 2014-07-17
JP5653911B2 (ja) 2015-01-14
FR2931073B1 (fr) 2010-08-20
CN104189005A (zh) 2014-12-10
KR20110023858A (ko) 2011-03-08
WO2009138517A1 (fr) 2009-11-19
MX2010012352A (es) 2010-12-07
IL209334A (en) 2015-08-31
AU2009248047A1 (en) 2009-11-19
HK1203828A1 (en) 2015-11-06
UA101035C2 (ru) 2013-02-25
CN102026632A (zh) 2011-04-20
PL2119435T3 (pl) 2012-01-31
MA32396B1 (fr) 2011-06-01
BRPI0912506B1 (pt) 2019-04-16
ATE523192T1 (de) 2011-09-15
CA2724522A1 (fr) 2009-11-19
ES2370465T3 (es) 2011-12-16
RU2493834C2 (ru) 2013-09-27
FR2931073A1 (fr) 2009-11-20
DK2119435T3 (da) 2011-11-21
NZ589971A (en) 2013-01-25
RU2010153201A (ru) 2012-06-27
CY1112150T1 (el) 2015-12-09
PT2119435E (pt) 2011-12-09
SI2119435T1 (sl) 2011-11-30
HRP20110905T1 (hr) 2011-12-31
IL209334A0 (en) 2011-01-31
JP2011520850A (ja) 2011-07-21
EP2119435A1 (fr) 2009-11-18
EP2119435B1 (fr) 2011-09-07
ZA201009033B (en) 2012-01-25

Similar Documents

Publication Publication Date Title
CY1112150T1 (el) Μαλακτικη συνθεση
Nowak et al. Epilobium angustifolium L. extracts as valuable ingredients in cosmetic and dermatological products
EP1698325B1 (en) Compositions containing amines and use thereof
Harrison et al. Breaking the itch–scratch cycle: topical options for the management of chronic cutaneous itch in atopic dermatitis
FR2890559B1 (fr) Mousses dermatologiques a base de metronidazole et emulsions pour la preparation
WO2009032773A3 (en) Compositions and methods for treating demodex infestations
JP2021532064A (ja) デンドロビウム・ノビルを含有する組成物およびその使用方法
Sadgrove et al. An updated etiology of hair loss and the new cosmeceutical paradigm in therapy: clearing ‘the big eight strikes’
WO2011157428A3 (de) In-situ lecithin-mikroemulsionsgel-formulierung
AU2018221880B2 (en) Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases
Wu et al. Effect of the tyrosinase inhibitor (S)-N-trans-feruloyloctopamine from garlic skin on tyrosinase gene expression and melanine accumulation in melanoma cells
WO2008013669A3 (en) Alpha hydroxy acid sustained release formulation
Marissa et al. Antioxidant and photoprotective activity of bromelain cream: An in vitro and in vivo study
ATE455536T1 (de) Topische zusammensetzung zur behandlung von schuppenflechte
DE50311088D1 (de) Verfahren zur herstellung von emulsionen
US20060257335A1 (en) Compositions containing amines and use thereof to darken the skin
DK1716845T3 (da) Formulering til dermal anvendelse
WO2022221960A1 (en) Compounds for treating proliferator-activated receptors (ppar) mediated diseases or conditions
JP2009114146A (ja) トランスグルタミナーゼ−１産生促進剤及びインボルクリン産生促進剤
AU2016250379B2 (en) Compositions containing amines and use thereof
DE602006019842D1 (de) Verwendung von lecithin als arzneimittel zur behandlung von psoriasis
Rusu et al. Bioactive Compounds for Topical and Minimally Invasive Cellulite Treatment and Skin Rejuvenation
BR112014032850B1 (pt) Uso de combinações de princípios ativos e uso de preparações cosméticas ou dermatológicas
AU2012201897B2 (en) Compositions containing amines and use thereof
Nunes Development of New Neutrophil Elastase Inhibitors for Topical Formulation with Improved Therapeutic Efficacy

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2009, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2671 DE 15-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.